Podcast appearances and mentions of cori bargmann

27 January 2023 - “I really think our special feature (as humans) is communication and shared knowledge,” neuroscientist Cori Bargmann told the EMBO podcast. Bargmann is the Torsten N. Wiesel Professor and Head of the Laboratory of Neural Circuits and Behavior at The Rockefeller University in New York, where her group studies neurobiology using C. elegans as their main model. Cori Bargmann has been an Associate EMBO Member since 2011. On this episode of the EMBO podcast we discussed the evolution of behavior, open science, a worm's sense of smell, the Human Brain Initiative, mentorship, and much more.

5 January 2023 - “Nobody is doubling the number of cell types,” says Steve Quake, “but what we have now is the full molecular portrait of those cell types”. Quake, who led a decade-long effort to create full organism molecular cell atlases, served for six years as co-President of the Chan Zuckerberg Biohub. He succeeded neuroscientist Cori Bargmann as Head of Science for the Chan Zuckerberg Initiative. Quake came to biology after undergraduate and graduate work in physics and mathematics, and his research group at Stanford has maintained a strong technological and quantitative focus. On this episode of the EMBO podcast, we discussed what a cell type is, Open Science and preprints (Quake and student Michael Swift are currently experimenting with Review Commons – “the jury's still out,” he says), the role of funders, how to start a company, and much more.

Cori Bargmann, PhD, head of science at the Chan Zuckerberg Initiative, head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior, and the Torsten N. Wiesel Professor at The Rockefeller University, delivered the keynote address at UMass Chan Medical School's 49th Commencement. Listen to Dr. Bargmann's full speech in this episode of the Voices of UMass Chan. Learn more about Dr. Bargmann in this video: https://www.umassmed.edu/news/news-archives/2022/06/video-inside-the-lives-and-accomplishments-of-cori-bargmann-paula-johnson-and-james-oconnell/ Read more about Commencement: https://www.umassmed.edu/news/news-archives/2022/02/umass-chan-medical-school-to-celebrate-classes-of-2022-at-49th-commencement-on-june-5/

Dr. Jennifer Garrison, PhD (http://garrisonlab.com/) is Assistant Professor, Buck Institute for Research on Aging, Founder & Faculty Director, Global Consortium for Reproductive Longevity & Equality (https://www.buckinstitute.org/gcrle/), Assistant Professor in Residence, Cellular and Molecular Pharmacology, UCSF and Adjunct Assistant Professor of Gerontology, USC Leonard Davis School of Gerontology. Dr. Garrison's lab is interested in understanding how neuropeptides (a large class of signaling molecules which are secreted from neurons and transmit messages within the brain and across the nervous system) regulate changes in normal and aging animals as well in understanding how they control behavior at both the cell biological and neural circuit level. Dr. Garrison received her PhD from the University of California San Francisco in Chemistry and Chemical Biology in the laboratory of Dr. Jack Taunton, where she discovered the molecular target of a natural product and elucidated a novel mechanism by which small molecules can regulate protein biogenesis. As a postdoctoral fellow in Dr. Cori Bargmann's lab at the Rockefeller University, she showed that the nematode C. elegans produces a neuropeptide that is an evolutionary precursor of the mammalian peptides vasopressin and oxytocin, and mapped a neural circuit by which this molecule, nematocin, modulates mating behavior. Dr. Garrison was named an Alfred P. Sloan Research Fellow and received a Glenn Foundation Award for Research in Biological Mechanisms of Aging in 2014, and a Next Generation Leader at the Allen Institute for Brain Science in 2015. Her work is funded by the NIH National Institute of General Medical Sciences, the Glenn Foundation for Medical Research, the Alfred P. Sloan Foundation, and the Larry L. Hillblom Foundation.

La tercera edición del congreso Santander Women Now reunirá la próxima semana en Madrid a algunas de las voces imprescindibles en la lucha contra la violencia, la desigualdad o el cambio climático, como la genetista Cori Bargmann, la astronauta Samantha Cristoforetti, la abogada Eva González y la activista Monde Balde. Además entramos en un centro 24 horas para personas sin hogar en el día en el que se han vacunado; y conocemos a Antonia Morillas, la nueva directora del Instituto de las Mujeres, que anuncia la reforma de la ley del aborto y la creación de una tasa morada. toleranciacero.rne@rtve.es Escuchar audio

Cori Bargmann is a neuroscientist and geneticist. She received a BS in biochemistry from the University of Georgia and a Ph.D. from the Massachusetts Institute of Technology. Cori has studied the relationships between genes, circuits, and behaviors in the genetically tractable nematode worm Caenorhabditis elegans as a faculty member at the University of California, San Francisco (1991-2004) and at the Rockefeller University as the Torsten N. Wiesel Professor and Head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior (2004-present). Cori’s work has been recognized by scientific honors including a 2012 Kavli Prize in Neuroscience, the 2013 Breakthrough Prize in Life Sciences, and she also co-chaired the NIH working group to the Advisory Committee to the NIH Director for President Obama’s Brain Initiative. In 2016, Cori joined the Chan Zuckerberg Initiative as its first Head of Science. CZI Science has the mission of supporting the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of the century.Referenced Links:HCA Method Development Community - https://www.protocols.io/workspaces/hcaCOVID-19 Cell Atlas - https://www.covid19cellatlas.org/CZI Science - https://chanzuckerberg.com/science/

Cori Bargmann is a neuroscientist and geneticist. She received a BS in biochemistry from the University of Georgia and a Ph.D. from the Massachusetts Institute of Technology. Cori has studied the relationships between genes, circuits, and behaviors in the genetically tractable nematode worm Caenorhabditis elegans as a faculty member at the University of California, San Francisco (1991-2004) and at the Rockefeller University as the Torsten N. Wiesel Professor and Head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior (2004-present). Cori's work has been recognized by scientific honors including a 2012 Kavli Prize in Neuroscience, the 2013 Breakthrough Prize in Life Sciences, and she also co-chaired the NIH working group to the Advisory Committee to the NIH Director for President Obama's Brain Initiative. In 2016, Cori joined the Chan Zuckerberg Initiative as its first Head of Science. CZI Science has the mission of supporting the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of the century. Referenced Links: HCA Method Development Community - https://www.protocols.io/workspaces/hca COVID-19 Cell Atlas - https://www.covid19cellatlas.org/ CZI Science - https://chanzuckerberg.com/science/

Alan talks with the woman who’s been given the job of leading the fight to conquer all disease by 2100. They discuss whether it’s actually possible and how her life has led her from studying a tiny transparent worm to such a challenging task. Support the show.

The neurogenetics pioneer Cori Bargmann speaks with host Steven Strogatz about why a transparent worm became her favorite animal and how a genetic discovery she made inspired a revolutionary cancer treatment. The post Cori Bargmann on the Genetics of Transparent Worms, Supertasters and Cancer first appeared on Quanta Magazine. The post Cori Bargmann on the Genetics of Transparent Worms, Supertasters and Cancer first appeared on Quanta Magazine

Cori Bargmann is the head of science at the Chan Zuckerberg Initiative. She is also the head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior and the Torsten N. Wiesel Professor at The Rockefeller University in New York. She joins the podcast to discuss advancing science on a larger scale.

How blocking tau protein tangles in the brain may combat neurodegeneration, with David Holtzman (0:00) (from Neuron). How the US government is betting big on neuroscience research, with Cori Bargmann (6:42) (from Cell). How a common virus is linked to several kinds of cancers, with Henri-Jacques Delecluse (16:50) (from Cell Reports). Plus, sample a selection of the hottest new papers from Cell Press (21:20).

Scientists in New York City are at the center of President Obama's brain research initiative, a $100 million effort to better understand the inner workings of the human noggin.  "For a lot of the way that different brain regions work together to generate complex functions, we're really stumbling around in the dark," said Dr. Cori Bargmann, a Rockefeller University neuroscientist and co-chair of the project. "The point of the brain initiative is to turn on some lights." This week on New Tech City, host Manoush Zomorodi sits down with Bargmann for an in-depth discussion of the program's objectives. "The living brain and the way that activity flows through the brain when you have a perception, or a memory, or an emotion or a thought are the things that really concern us," she said. President Obama announced the BRAIN initiative in April. Yes, like much of Washington-speak, it's an acronym: Brain Research through Advancing Innovative Neurotechnologies. Just don't call it brain mapping.  "A map is something static, and the whole point of the brain is that it's always moving," Bargmann said. "If you want to think of it as a map at all, you should think of it more as a Google Map that shows where the traffic is moving." If only human heads and brains were translucent like zebrafish heads and brains, you might even be able to see what Bargmann describes as "neurons...twinkling like stars in the sky."  Also in this week's show, WNYC business and economics editor Charlie Herman visits a new biotechnology lab in Harlem called the Harlem Biospace where biotech entrepreneurs can make discoveries and turn them into businesses. New York has nine major medical centers and is a major center for biomedical science, according to the lab's founder Sam Sia, but there are still barriers for entrepreneurs working in biosciences in the city.  "The issues so far with translating some of the research into inventions and products is that there hasn't been a place to get started for people in terms of a lab for the one- or two-person startup," he said. This is an extended podcast of New Tech City. You can listen to the broadcast version every Wednesday morning at 5:50 and 7:50 a.m. on WNYC 93.9 FM, AM 820 and New Jersey Public Radio or subscribe to the program on iTunes.

In this month's Cell Podcast, we learn about altering neuronal circuits depending on the environment, with Cori Bargmann (0:00) (Forthcoming Cell Symposia on Neuromodulatory Mechanisms), the role of mitochondria in diabetes, with Orian Shirihai (8:30) (Trends in Endocrinology and Metabolism September Special issue), and how the power of the placebo has evolved over time, with Nicholas Humphrey (15:05) (Current Biology September Special issue). Plus, sample a selection of the hottest new papers from Cell Press (25:20).

A neurobiologist studies social behaviors and neuromodulation